Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease? (Q38071012)

28 August 2017

1 reference

title

Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease? (English)

1 reference

28 August 2017

main subject

cardiovascular disease

1 reference

1 reference

1 reference

Farid Saad

1 reference

28 August 2017

publication date

1 December 2012

1 reference

Diabetes - Metabolism: Research and Reviews

28 August 2017

published in

1 reference

28 August 2017

volume

28 Suppl 2

1 reference

28 August 2017

page(s)

52-59

1 reference

Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women

28 August 2017

cites work

1 reference

Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes

21 January 2018

1 reference

Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.

21 January 2018

1 reference

Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data

21 January 2018

1 reference

Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients

21 January 2018

1 reference

Testosterone, cardiovascular disease and the metabolic syndrome

21 January 2018

1 reference

Testosterone deficiency as a risk factor for cardiovascular disease.

21 January 2018

1 reference

Testosterone, hemostasis, and cardiovascular diseases in men.

21 January 2018

1 reference

Testosterone and modifiable risk factors associated with diabetes in men.

21 January 2018

1 reference

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis

21 January 2018

1 reference

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

Testosterone therapy: treatment of metabolic disturbances in heart failure

21 January 2018

1 reference

Adverse Events Associated with Testosterone Administration

21 January 2018

1 reference

Low serum testosterone and increased mortality in men with coronary heart disease

21 January 2018

1 reference

Testosterone levels and cardiovascular disease.

21 January 2018

1 reference

Testosterone and cardiovascular disease: an old idea with modern clinical implications.

21 January 2018

1 reference

Testosterone and coronary artery disease

21 January 2018

1 reference

Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients

21 January 2018

1 reference

The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese men

21 January 2018

1 reference

Testosterone deficiency and replacement in older men.

21 January 2018

1 reference

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure

21 January 2018

1 reference

Adverse events associated with testosterone administration

21 January 2018

1 reference

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

Testosterone and heart failure

21 January 2018

1 reference

Testosterone deficiency syndrome (TDS) and the heart

21 January 2018

1 reference

Testosterone as an atrial fibrillation treatment and stroke preventative in aging men: case histories and hypothesis

21 January 2018

1 reference

Testosterone deficiency: a risk factor for cardiovascular disease?

21 January 2018

1 reference

Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men.

21 January 2018

1 reference

Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men.

21 January 2018

1 reference

Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites

21 January 2018

1 reference

Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease.

21 January 2018

1 reference

Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

21 January 2018

1 reference

Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study

21 January 2018

1 reference

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study

21 January 2018

1 reference

Metabolic syndrome, testosterone, and cardiovascular mortality in men.

21 January 2018

1 reference

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

21 January 2018

1 reference

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

21 January 2018

1 reference

Elevated high sensitivity C-reactive protein levels in aging men with low testosterone

21 January 2018

1 reference

Insulin sensitivity during combined androgen blockade for prostate cancer

21 January 2018

1 reference

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth

21 January 2018

1 reference

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

21 January 2018

1 reference

Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes

21 January 2018

1 reference

Metabolic complications of androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

21 January 2018

1 reference

21 January 2018

Testosterone deficiency

1 reference

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men.

21 January 2018

1 reference

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

21 January 2018

1 reference

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

21 January 2018

1 reference

Acute haemodynamic effects of testosterone in men with chronic heart failure

21 January 2018

1 reference

Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease

21 January 2018

1 reference

Sex hormones and hypertension

21 January 2018

1 reference

Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin

21 January 2018

1 reference

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

21 January 2018

1 reference

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

21 January 2018

1 reference

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency

21 January 2018

1 reference

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

21 January 2018

1 reference

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.

21 January 2018

1 reference

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

21 January 2018

1 reference

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

21 January 2018

1 reference

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

21 January 2018

1 reference

Effects of Transdermal Testosterone on Bone and Muscle in Older Men with Low Bioavailable Testosterone Levels, Low Bone Mass, and Physical Frailty

21 January 2018

1 reference

Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease.

21 January 2018

1 reference

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

21 January 2018

1 reference

The dark side of testosterone deficiency: III. Cardiovascular disease

21 January 2018

1 reference

Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction

21 January 2018

1 reference

Testosterone replacement therapy and cardiovascular risk factors modification

21 January 2018

1 reference

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

21 January 2018

1 reference

The association of hypotestosteronemia with coronary artery disease in men

21 January 2018

1 reference

7 January 2021

Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography

1 reference

7 January 2021

Low Serum Testosterone Is Associated with Increased Mortality in Men with Stage 3 or Greater Nephropathy

1 reference

7 January 2021

Endogenous testosterone levels and cardiovascular disease in healthy men

1 reference

7 January 2021

Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia.

1 reference

7 January 2021

Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular diseases

1 reference

7 January 2021

Androgens and cardiovascular disease

1 reference

7 January 2021

Low testosterone levels are associated with carotid atherosclerosis in men

1 reference

7 January 2021

Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease

1 reference

7 January 2021

Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation

1 reference

7 January 2021

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

7 January 2021

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

7 January 2021

Longitudinal Relation between Endogenous Testosterone and Cardiovascular Disease Risk Factors in Middle-aged Men: A 13-Year Follow-up of Former Multiple Risk Factor Intervention Trial Participants

1 reference

7 January 2021

Sex hormones, insulin, lipids, and prevalent ischemic heart disease

1 reference

7 January 2021

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.2354

1 reference

28 August 2017

1 reference